Im Ellie Eunkyung
SEC insider (Form 3/4/5 filer). CIK 0002075219. Chief Medical Officer at CRESCENT BIOPHARMA, INC. (CBIO). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in WALTHAM, MA.
Companies Im Ellie Eunkyung has filed insider reports for
- CRESCENT BIOPHARMA, INC. (CBIO): Officer, Chief Medical Officer
Im Ellie Eunkyung
CIK: 0002075219
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CBIO
CRESCENT BIOPHARMA, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 16, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect623 shares at avg. $17.90$11K - Jun 22, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect1.2K shares at avg. $17.99$22K - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect16.3K shares- - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect5K shares-
1-4 of 4 transactions